Søren Toubro

4.5k total citations · 2 hit papers
68 papers, 3.5k citations indexed

About

Søren Toubro is a scholar working on Physiology, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Søren Toubro has authored 68 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Physiology, 16 papers in Pharmacology and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Søren Toubro's work include Diet and metabolism studies (32 papers), Adipose Tissue and Metabolism (17 papers) and Pharmacology and Obesity Treatment (16 papers). Søren Toubro is often cited by papers focused on Diet and metabolism studies (32 papers), Adipose Tissue and Metabolism (17 papers) and Pharmacology and Obesity Treatment (16 papers). Søren Toubro collaborates with scholars based in Denmark, Russia and United States. Søren Toubro's co-authors include Arne Astrup, B Buemann, Bjørn Richelsen, Camilla Verdich, Anne Raben, Jens Meldgaard Bruun, Aina S. Lihn, Steen B. Pedersen, Thomas Meinert Larsen and Thorkild I. A. Sørensen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and PLoS ONE.

In The Last Decade

Søren Toubro

68 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans

2003 616 citations Jens Meldgaard Bruun, Søren Toubro et al. profile →
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study

2025 19 citations Søren Toubro, Arne Heydorn et al. The Lancet profile →

Peers

Countries citing papers authored by Søren Toubro

Since Specialization

Citations

This map shows the geographic impact of Søren Toubro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Søren Toubro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Søren Toubro more than expected).

Fields of papers citing papers by Søren Toubro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Søren Toubro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Søren Toubro. The network helps show where Søren Toubro may publish in the future.

Co-authorship network of co-authors of Søren Toubro

This figure shows the co-authorship network connecting the top 25 collaborators of Søren Toubro. A scholar is included among the top collaborators of Søren Toubro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Søren Toubro. Søren Toubro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial 2025 ·The Lancet ·(unknown), Arne Heydorn, Sanaz Gabery, Julie Hjerpsted, (unknown), Thomas Kruse, Solveig Petersen, Søren Toubro, Andreas Vegge, (unknown)	15
2	Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: Effects on weight loss and safety in adults with overweight or obesity 2023 ·Molecular Metabolism ·Martin Friedrichsen, Lars Endahl, Frederik Flindt Kreiner, Ronald Goldwater, Martin Kankam, Søren Toubro, Sune Boris Nygård	27
3	The effect of three different ad libitum diets for weight loss maintenance: a randomized 18-month trial 2015 ·European Journal of Nutrition ·Anette Due, Thomas Meinert Larsen, Huiling Mu, Kjeld Hermansen, Steen Stender, Søren Toubro, David B. Allison, Arne Astrup	10
4	Sustained Weight Loss during 20 Months using a Personalized Interactive Internet Based Dietician Advice Program in a General Practice Setting 2011 ·University of Southern Denmark Research Portal (University of Southern Denmark) ·(unknown), Carl J. Brandt, Dorte Glintborg, (unknown), Søren Toubro, Kirsten Brandt	6
5	Associations between APOE Variants and Metabolic Traits and the Impact of Psychological Stress 2011 ·PLoS ONE ·Sofia I. Iqbal Kring, John C. Barefoot, Beverly H. Brummett, Stephen H. Boyle, Ilene C. Siegler, Søren Toubro, Torben Hansen, Arne Astrup, Oluf Pedersen, Redford B. Williams, Thorkild I. A. Sørensen	7
6	Center‐Size as a Predictor of Weight‐Loss Outcome in Multicenter Trials Including a Low‐Calorie Diet 2010 ·Obesity ·Christoph Gasteyger, Robin Christensen, Thomas Meinert Larsen, Frank Vercruysse, Søren Toubro, Arne Astrup	2
7	A Randomized Trial of Lifestyle Modification and Taranabant for Maintaining Weight Loss Achieved With a Low‐Calorie Diet 2010 ·Obesity ·Thomas A. Wadden, Ken Fujioka, Søren Toubro, Ira Gantz, Ngozi Erondu, Menghui Chen, Shailaja Suryawanshi, (unknown), Amy O. Johnson‐Levonas, Deborah R. Shapiro, Keith D. Kaufman, Steven B. Heymsfield, John M. Amatruda	24
8	Conjugated Linoleic Acids Reduce Body Fat in Healthy Postmenopausal Women 2009 ·Journal of Nutrition ·Marianne Raff, Tine Tholstrup, Søren Toubro, Jens Meldgaard Bruun, Pia Lund, Ellen Marie Straarup, Robin Christensen, Maria Boysen Sandberg, Susanne Mandrup	36
9	Comparison of the effects on insulin resistance and glucose tolerance of 6-mo high-monounsaturated-fat, low-fat, and control diets 2008 ·American Journal of Clinical Nutrition ·Anette Due, Thomas Meinert Larsen, Kjeld Hermansen, Steen Stender, Jens J. Holst, Søren Toubro, Torben Martinussen, Arne Astrup	85
10	NPY5R Antagonism Does Not Augment the Weight Loss Efficacy of Orlistat or Sibutramine 2007 ·Obesity ·Ngozi Erondu, Carol Addy, Kaifeng Lu, Madhuja Mallick, Bret J. Musser, Ira Gantz, Joseph Proietto, Arne Astrup, Søren Toubro, (unknown), Serena Tonstad, William G. Haynes, Keith Gottesdiener, Keith D. Kaufman, John M. Amatruda, Steven B. Heymsfield	23
11	Mutation analysis of the preproghrelin gene: No association with obesity and type 2 diabetes 2005 ·Clinical Biochemistry ·Lesli H. Larsen, Anette P. Gjesing, Thorkild I. A. Sørensen, Yasmin H. Hamid, Søren M. Echwald, Søren Toubro, Eva Black, Arne Astrup, Torben Hansen, Oluf Pedersen	47
12	The N363S Polymorphism of the Glucocorticoid Receptor and Metabolic Syndrome Factors in Men 2005 ·Obesity Research ·B Buemann, Eva Black, Claus Holst, Søren Toubro, Søren M. Echwald, Oluf Pedersen, Arne Astrup, Thorkild I. A. Sørensen	16
13	Novel Variants in the Putative Peroxisome Proliferator‐activated Receptor γ Promoter and Relationships with Obesity in Men 2005 ·Obesity Research ·Thomas Meinert Larsen, Lesli H. Larsen, Signe S. Torekov, Jakob Ek, Eva Black, Søren Toubro, Arne Astrup, Grith Lykke Sørensen, Torben Hansen, Oluf Pedersen	3
14	Topiramate: A New Potential Pharmacological Treatment for Obesity* 2004 ·Obesity Research ·Arne Astrup, Søren Toubro	60
15	Effect of a 28-d treatment with L-796568, a novel β3-adrenergic receptor agonist, on energy expenditure and body composition in obese men 2002 ·American Journal of Clinical Nutrition ·Thomas Meinert Larsen, Søren Toubro, Marleen A. van Baak, Keith Gottesdiener, Patrick Larson, Wim H. M. Saris, Arne Astrup	137
16	Fat Mass Measured by DXA Varies with Scan Velocity 2002 ·Obesity Research ·Eva Black, Liselotte Petersen, (unknown), Søren Toubro, Thorkild I. A. Sørensen, Oluf Pedersen, Arne Astrup	23
17	D-Tagatose, a stereoisomer of D-fructose, increases blood uric acid concentration 2000 ·Metabolism ·B Buemann, Søren Toubro, Jens J. Holst, Jens F. Rehfeld, Bo Martin Bibby, Arne Astrup	43
18	Human Gastrointestinal Tolerance tod-Tagatose 1999 ·Regulatory Toxicology and Pharmacology ·B Buemann, Søren Toubro, Arne Astrup	37
19	Day-to-day variability of 24-h energy expenditure, respiratory quotient, macronutrient oxidation, and physical activity measured in a respiratory chamber 1994 ·American Journal of Clinical Nutrition ·Søren Toubro, Arne Astrup	1
20	The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women 1992 ·Metabolism ·Arne Astrup, B Buemann, Niels Juel Christensen, Søren Toubro, G. Thorbek, (unknown), F Quaade	63

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact